VIM and hepatocellular carcinoma: In hepatoma, Twist1 can promote vimentin expression, and it has been verified that Twist1 is combined with a circular RNA, the promoter region of CUL2 (Cullin-2), and promotes the mRNA of vimentin by adsorbing the microRNA targeting vimentin degradation, resulting in EET [127].